Carbamic Acid

Carbamic Acid

SCHEMBL4557656

CCNC(=O)NCCc1ccc(N2CC(=O)NS2(=O)=O)c(O)c1.NC(=O)O.O=C1CN(c2ccc(CCNC(=O)NC34CC5CC(CC(C5)C3)C4)cc2O)S(=O)(=O)N1.O=C1CN(c2ccc(CCNC(=O)NC3CCCCC3)cc2O)S(=O)(=O)N1.O=C1CN(c2ccc(CCNC(=O)Nc3ccccc3)cc2O)S(=O)(=O)N1

nearest known ligand 0.39

Full drug profile on Sugi Atlas →

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.39
POLB P06746 1/20 0.39
EPHX2 P34913 10/20 0.36
EPHX1 P07099 7/20 0.36
NPC1 O15118 2/20 0.36
RAB9A P51151 2/20 0.36
TP53 P04637 1/20 0.36
TSHR P16473 1/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
LMNA P02545 2/20 0.35
ALDH1A1 P00352 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
ATM Q13315 1/20 0.34
F10 P00742 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2936239 0.86 EPHX1 (0.48) SMN1; SMN2EPHX2EPHX1NPC1RAB9A
SCHEMBL2935066 0.81 NPC1 (0.51) SMN1; SMN2POLBEPHX2EPHX1NPC1
SCHEMBL3762437 0.80 EPHX1 (0.49) SMN1; SMN2POLBEPHX2EPHX1NPC1
SCHEMBL3759377 0.78 PTPN1 (0.46) SMN1; SMN2EPHX1NPC1RAB9AMEN1
SCHEMBL3262018 0.77 EPHX2 (0.52) SMN1; SMN2POLBEPHX2EPHX1NPC1
SCHEMBL2933013 0.76 PTPN1 (0.47) MEN1KMT2ALMNAALDH1A1
SCHEMBL3204480 0.76 EPHX1 (0.50) SMN1; SMN2EPHX2EPHX1NPC1RAB9A
SCHEMBL3225753 0.74 EPHX1 (0.49) SMN1; SMN2EPHX1TP53MEN1KMT2A
SCHEMBL2936042 0.73 PTPN1 (0.42) SMN1; SMN2EPHX2EPHX1NPC1RAB9A
SCHEMBL2936238 0.70 PTPN1 (0.39) SMN1; SMN2POLBTP53ALDH1A1ATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2089026-A2 INHIBITORS OF PROTEIN TYROSINE PHOSPHATASE FOR THE PROMOTION OF PHYSIOLOGICAL CARDIAC HYPERTROPHY Novartis AG (CH) 2009-08-19 EP disclosed
WO-2008070552-A2 INHIBITORS OF PROTEIN TYROSINE PHOSPHATASE FOR THE PROMOTION OF PHYSIOLOGICAL CARDIAC HYPERTROPHY NOVARTIS AG (CH) 2008-06-12 WO disclosed